Evidence map›Paper›PMID 30628436›Full record

ArticleBiochemistry2019

Spectroscopic and Electrochemical Characterization of the Mycofactocin Biosynthetic Protein, MftC, Provides Insight into Its Redox Flipping Mechanism.

Richard Ayikpoe, Thacien Ngendahimana, Michelle Langton, Sheila Bonitatibus, Lindsey M Walker, Sandra S Eaton, Gareth R Eaton, Maria-Eirini Pandelia, Sean J Elliott, John A Latham

Abstract read
In one paragraph

Article in Biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. RadicalJournal of the American Chemical Society · 2022
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Characterization of Fe-S Clusters in Proteins by Mӧssbauer Spectroscopy.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Richard AyikpoeDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.
Thacien NgendahimanaDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.
Michelle LangtonDepartment of Biochemistry , Brandeis University , Waltham , Massachusetts 02453 , United States.
Sheila BonitatibusDepartment of Chemistry , Boston University , Boston , Massachusetts 02215 , United States.
Lindsey M WalkerDepartment of Chemistry , Boston University , Boston , Massachusetts 02215 , United States.
Sandra S EatonDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.
Gareth R EatonDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.
Maria-Eirini PandeliaDepartment of Biochemistry , Brandeis University , Waltham , Massachusetts 02453 , United States.
Sean J ElliottDepartment of Chemistry , Boston University , Boston , Massachusetts 02215 , United States.ORCID 0000-0003-0096-9551
John A LathamDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.ORCID 0000-0002-3034-1768

Funding

Preclinical Electron Paramagnetic Resonance Tumor ImagerR01CA177744 · NCI · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, GARETH R · 2014 to 2019
$2.7M
Elucidating the biosynthesis of mycofactocin, an unknown molecule essential for M. tuberculosisR01GM124002 · NIGMS · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, SANDRA S. · 2017 to 2021
$1.6M
Redox Reactions of the AdoMet Radical Enzyme SuperfamilyR01GM120283 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI ELLIOTT, SEAN J · 2016 to 2019
$1.3M
Functional diversification of the HD-superfamily; the Hydrolase/Oxygenase DilemmaR00GM111978 · NIGMS · BRANDEIS UNIVERSITY · PI PANDELIA, MARIA-EIRINI · 2016 to 2018
$740k
Functional diversification of the HD-superfamily; the Hydrolase/Oxygenase DilemmaK99GM111978 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PANDELIA, MARIA-EIRINI · 2014 to 2015
$107k
NCI NIH HHS R01 CA177744NIGMS NIH HHS K99 GM111978NIGMS NIH HHS R00 GM111978NIGMS NIH HHS R01 GM120283NIGMS NIH HHS R01 GM124002
6 · The paper itself

Abstract

Mycofactocin is a putative redox cofactor and is classified as a ribosomally synthesized and post-translationally modified peptide (RiPP). Some RiPP natural products, including mycofactocin, rely on a radical S-adenosylmethionine (RS, SAM) protein to modify the precursor peptide. Mycofactocin maturase, MftC, is a unique RS protein that catalyzes the oxidative decarboxylation and C-C bond formation on the precursor peptide MftA. However, the number, chemical nature, and catalytic roles for the MftC [Fe-S] clusters remain unknown. Here, we report that MftC binds a RS [4Fe-4S] cluster and two auxiliary [4Fe-4S] clusters that are required for MftA modification. Furthermore, electron paramagnetic resonance spectra of MftC suggest that SAM and MftA affect the environments of the RS and Aux I cluster, whereas the Aux II cluster is unaffected by the substrates. Lastly, reduction potential assignments of individual [4Fe-4S] clusters by protein film voltammetry show that their potentials are within 100 mV of each other.

Indexed as

Bacterial ProteinsCatalysisCatalytic DomainCysteineElectrochemical TechniquesElectron Spin Resonance SpectroscopyIron-Sulfur ProteinsMycobacterium ulceransOxidation-ReductionS-AdenosylmethionineSpectroscopy, MossbauerBacterial ProteinsCysteineIron-Sulfur ProteinsS-Adenosylmethionine

Identifiers

PMID30628436
PMCPMC6380935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.